Walid Shalata

Beersheba, D 84105, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 84 publications

De Novo Actionable Genomic Alterations in High-Grade Pulmonary Neuroendocrine Carcinomas: Therapeutic Implications of Targeted Treatment.

De Novo Actionable Genomic Alterations in High-Grade Pulmonary Neuroendocrine Carcinomas: Therapeutic Implications of Targeted Treatment.

Journal: Medical sciences (Basel, Switzerland)

Published: July 03, 2026

Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) on the Efficacy of Immunotherapy in Metastatic NSCLC.

Impact of Angiotensin-Converting Enzyme Inhibitors (ACEIs) on the Efficacy of Immunotherapy in Metastatic NSCLC.

Journal: Medical sciences (Basel, Switzerland)

Published: June 26, 2026

Social Network Clustering Analysis for Detection of Associated Genetic Co-Mutations in Patients with Actionable Driver Mutations in NSCLC.

Social Network Clustering Analysis for Detection of Associated Genetic Co-Mutations in Patients with Actionable Driver Mutations in NSCLC.

Journal: Life (Basel, Switzerland)

Published: May 13, 2026

Impact of EGFR variant allele frequency on treatment-related adverse events in patients with metastatic NSCLC treated with osimertinib.

Impact of EGFR variant allele frequency on treatment-related adverse events in patients with metastatic NSCLC treated with osimertinib.

Journal: Frontiers in molecular biosciences

Published: May 11, 2026

Evaluating the Role of Chemotherapy in Addition to Radiotherapy for High-Risk Merkel Cell Carcinoma.

Evaluating the Role of Chemotherapy in Addition to Radiotherapy for High-Risk Merkel Cell Carcinoma.

Journal: Medical sciences (Basel, Switzerland)

Published: April 24, 2026

Optimal Duration of Adjuvant Platinum-Etoposide in High-Risk Merkel Cell Carcinoma.

Optimal Duration of Adjuvant Platinum-Etoposide in High-Risk Merkel Cell Carcinoma.

Journal: Medicina (Kaunas, Lithuania)

Published: March 30, 2026

Impact of Variant Allele Frequency (VAF) Levels on Clinical Efficacy of Osimertinib in Patients with Metastatic NSCLC.

Impact of Variant Allele Frequency (VAF) Levels on Clinical Efficacy of Osimertinib in Patients with Metastatic NSCLC.

Journal: Medical sciences (Basel, Switzerland)

Published: March 10, 2026

Survival Outcomes in Lymph Node-Positive Merkel Cell Carcinoma (Stage III): A Comparison Between Known and Unknown Primary Tumors and Their Sun Exposure Sites.

Survival Outcomes in Lymph Node-Positive Merkel Cell Carcinoma (Stage III): A Comparison Between Known and Unknown Primary Tumors and Their Sun Exposure Sites.

Journal: Medical sciences (Basel, Switzerland)

Published: March 09, 2026

Variant allele frequency as a predictor of treatment response to osimertinib in EGFR-mutated NSCLC.

Variant allele frequency as a predictor of treatment response to osimertinib in EGFR-mutated NSCLC.

Journal: Frontiers in molecular biosciences

Published: March 03, 2026

Impact of PD-L1 Status on the Development of Cutaneous Immune-Related Adverse Events in Non-Small-Cell Lung Cancer Patients Receiving Immunotherapy.

Impact of PD-L1 Status on the Development of Cutaneous Immune-Related Adverse Events in Non-Small-Cell Lung Cancer Patients Receiving Immunotherapy.

Journal: Life (Basel, Switzerland)

Published: March 02, 2026

Real-world treatment patterns and outcomes of chemo-immunotherapy with or without radiotherapy in extensive-stage small cell lung cancer: the durvalumab expanded access cohort.

Real-world treatment patterns and outcomes of chemo-immunotherapy with or without radiotherapy in extensive-stage small cell lung cancer: the durvalumab expanded access cohort.

Journal: Frontiers in oncology

Published: March 02, 2026

Investigation of the Prevalence of Associated Genetic Mutations (Co-Mutations) in Patients with Actionable Driver Mutations in Lung Cancer: A Retrospective Study.

Investigation of the Prevalence of Associated Genetic Mutations (Co-Mutations) in Patients with Actionable Driver Mutations in Lung Cancer: A Retrospective Study.

Journal: Diagnostics (Basel, Switzerland)

Published: February 06, 2026

Showing 1-12 of 84

Last Updated: 09/26/2026